Global ETD Search

Verlaufsuntersuchung von Patienten mit multipler Sklerose unter einer Behandlung mit Natalizumab (Tysabri®) unter besonderer Berücksichtigung der Kernspintomographie

Lührmann, Anna FabiaUniversität Ulm

ulm-diss Repository record for Verlaufsuntersuchung von Patienten mit multipler Sklerose unter einer Behandlung mit Natalizumab (Tysabri®) unter besonderer Berücksichtigung der Kernspintomographie (opens in a new tab)

A qualitative study of healthcare workers' and patients' perspectives on changing the model of care from outpatient to in-home for the infusion of natalizumab

Juaton, Mahasen2020

… and cost effectiveness of flexible delivery of natalizumab by ambulatory care nurses for people with multiple sclerosis. Currently, people with multiple sclerosis receive natalizumab intravenous infusions through an outpatient intravenous therapy service. Using a hospital in the home model to …

adelaide Repository record for A qualitative study of healthcare workers' and patients' perspectives on changing the model of care from outpatient to in-home for the infusion of natalizumab (opens in a new tab)

Mobilisation, Isolation and Coculture of Haematopoietic Stem Cells

Jing, DuohuiTechnische Universität Dresden

… stem cells (HSC). Therapeutic application of natalizumab, an anti-CD49d antibody, in patients with multiple sclerosis (MS) has been associated with increased levels of circulating CD34+ progenitors. In our study (part 2 of the chapter “Results and discussions”), we compared circulating HSCs …

qucosa-diss

Imaging and therapy in multiple sclerosis

Brown, James William LyleUniversity of Cambridge2020

… with RRMS, initial treatment with fingolimod, natalizumab or alemtuzumab was associated with a lower risk of conversion to SPMS compared to initial treatment with glatiramer acetate or interferon beta over a median 5.8 years of follow-up. A lower risk of conversion was also associated with …

cambridge Repository record for Imaging and therapy in multiple sclerosis (opens in a new tab)